Raffaele Ingenito
13Patents
2h-index
50Co-inventors
53Inventor score
Filing activity: Dec 9, 2005 → Sep 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11530244B2 | Cyclic polypeptides for PCSK9 inhibition | Human Necessities | 4 | Active |
| US7863294B2 | Heterocycle derivatives as histone deacetylase (HDAC) inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10961295B2 | Modified lipidated Relaxin B chain peptides and their therapeutic use | Human Necessities | 1 | Active |
| US10988524B2 | Modified relaxin B chain peptides and their therapeutic use | Human Necessities | 1 | Active |
| US10988523B2 | Modified lipidated Relaxin B chain peptides and their therapeutic use | Human Necessities | 1 | Active |
| US8362030B2 | Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) | Chemistry; Metallurgy | 1 | Active |
| US12018057B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Human Necessities | 0 | Active |
| US11306125B2 | PCSK9 antagonists bicyclo-compounds | Human Necessities | 0 | Active |
| US11725036B2 | Modified lipidated relaxin B chain peptides and their therapeutic use | Human Necessities | 0 | Active |
| US8026265B2 | Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11505575B2 | Cyclic polypeptides for PCSK9 inhibition | Human Necessities | 0 | Active |
| US11932705B2 | Cyclic polypeptides for PCSK9 inhibition | Human Necessities | 0 | Active |
| US12012468B2 | Cyclic polypeptides for PCSK9 inhibition | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.